Treating Obesity Like the Disease It Is For Dr
and with injectable peptides broadly, theres a risk of transient injection-site reactions such as pain, itching, swelling, or redness.21 Insider Tip: There are ways to mitigate the potential nausea associated with peptides
Their ability to support appetite regulation, metabolic control, and sustained weight reduction when combined with structured clinical support - makes them a promising option for many patients
Available evidence suggests that these agents have similar efficacy, for example: An RCT comparing valproic acid and lacosamide found that the agents were equally efficacious when adequately dosed (e.g., 400 mg IV lacosamide)
But then a compound was discovered that activates GLP-1 activity, but was resistant to enzyme breakdown
G.et al (2021b)